AI assistant
LEMAITRE VASCULAR INC — Director's Dealing 2017
Dec 27, 2017
31708_dirs_2017-12-27_39fda0f6-a276-4bd5-b932-35639c47d71c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2017-12-22
Reporting Person: Kamke Trent G (Senior V. P., Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-22 | Common Stock | A | 919 | $0.00 | Acquired | 16354 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-12-22 | Stock Option (Right to Buy) | $31.30 | A | 7959 | Acquired | 2024-12-22 | Common Stock (7959) | Direct |
Footnotes
F1: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F2: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.